CLINICAL_TRIALS
trial_result
· 2018-05-11
Clinical Trial Update: Assessing the Role of a Fermented Soy Extract in Inflammation and the Human Microbiome [Phase 1]
Summary
Phase 1 trial evaluating fermented soy extract for inflammation and the human microbiome in obesity has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Obesity | Phase 1 | Status: COMPLETED